Galmed Pharmaceuticals
GLMD
#11038
Rank
NZ$9.04 M
Marketcap
NZ$8.46
Share price
21.05%
Change (1 day)
403.48%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2026 (TTM): NZ-$21.93

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$23.54. In 2017 the company made an earnings per share (EPS) of NZ-$2,580 an increase over its 2016 EPS that were of NZ-$3,922.

EPS history for Galmed Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$21.93
2017NZ-$2,580-34.23%
2016NZ-$3,92256.84%
2015NZ-$2,501

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Evoke Pharma
EVOK
NZ-$4.61-80.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
NZ-$1.96-91.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ-$1.37-94.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
NZ-$11.57-50.85%๐Ÿ‡บ๐Ÿ‡ธ USA